4//SEC Filing
Ratliff John D 4
Accession 0001127602-18-014165
CIK 0000920148other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 10:14 AM ET
Size
5.6 KB
Accession
0001127602-18-014165
Insider Transaction Report
Form 4
Ratliff John D
CEO, Covance Drug Development
Transactions
- Award
Restricted Stock Unit
2018-04-03+12,120→ 26,337 total→ Common Stock (12,120 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]The Restricted Stock Units will vest in three installments as follows: 20% of the Restricted Stock Units will vest on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021.
- [F3]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Documents
Issuer
LABORATORY CORP OF AMERICA HOLDINGS
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001575951
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 10:14 AM ET
- Size
- 5.6 KB